Literature DB >> 31913961

Prevalence of Mild Cognitive Impairment in the Elderly Population in Greece: Results From the HELIAD Study.

George S Vlachos1, Mary H Kosmidis2, Mary Yannakoulia3, Efthimios Dardiotis4, Georgios Hadjigeorgiou4,5, Paraskevi Sakka6, Eva Ntanasi1,6, Leonidas Stefanis1,7, Nikolaos Scarmeas1,8.   

Abstract

INTRODUCTION: Timely recognition of mild cognitive impairment (MCI) is essential in optimizing prevention and treatment for Alzheimer disease. Because of the paucity of data on MCI epidemiology in Greece and the variability of worldwide published results, we investigated the prevalence and determinants of MCI in the elderly population in Greece.
METHODS: As part of the Hellenic Epidemiological Longitudinal Investigation of Aging and Diet (HELIAD), we randomly selected 1960 individuals 65 years and older to undergo full neurological and neuropsychological assessment by a multidisciplinary team. MCI was diagnosed according to the Petersen criteria.
RESULTS: The age-standardized and gender-standardized prevalence of MCI in people aged 65 years and older in Greece is 13.11%. The amnestic and multidomain MCI subtypes are more common than their nonamnestic and single-domain counterparts, respectively. Almost two thirds of cases are because of suspected Alzheimer disease. Every additional year of age increases the odds of prevalent MCI by 7.4%, every additional year of education decreases the odds of MCI by 6.3%, and apolipoprotein E (APOE-ε4) carriage increases the odds of MCI by 57.9%.
CONCLUSIONS: MCI prevalence in the elderly population in Greece is on par with previously reported rates. Prospective studies with robust methodology will enhance our understanding of the dementia continuum.

Entities:  

Mesh:

Year:  2020        PMID: 31913961     DOI: 10.1097/WAD.0000000000000361

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  5 in total

1.  Incidence of mild cognitive impairment in the elderly population in Greece: results from the HELIAD study.

Authors:  George S Vlachos; Mary H Kosmidis; Mary Yannakoulia; Efthimios Dardiotis; Georgios Hadjigeorgiou; Ioanna Tzoulaki; Andrea N Georgiou; Paraskevi Sakka; Costas A Anastasiou; Leonidas Stefanis; Nikolaos Scarmeas
Journal:  Aging Clin Exp Res       Date:  2021-03-08       Impact factor: 3.636

2.  Prevalence of mild cognitive impairment in community-dwelling Chinese populations aged over 55 years: a meta-analysis and systematic review.

Authors:  Yuan Lu; Chaojie Liu; Dehua Yu; Sally Fawkes; Jia Ma; Min Zhang; Chunbo Li
Journal:  BMC Geriatr       Date:  2021-01-06       Impact factor: 3.921

3.  Cognitive Impairment and Dementia in Primary Care: Current Knowledge and Future Directions Based on Findings From a Large Cross-Sectional Study in Crete, Greece.

Authors:  Antonios Bertsias; Emmanouil Symvoulakis; Chariklia Tziraki; Symeon Panagiotakis; Lambros Mathioudakis; Ioannis Zaganas; Maria Basta; Dimitrios Boumpas; Panagiotis Simos; Alexandros Vgontzas; Christos Lionis
Journal:  Front Med (Lausanne)       Date:  2020-11-23

4.  The complex burden of determining prevalence rates of mild cognitive impairment: A systematic review.

Authors:  Maria Casagrande; Giulia Marselli; Francesca Agostini; Giuseppe Forte; Francesca Favieri; Angela Guarino
Journal:  Front Psychiatry       Date:  2022-09-23       Impact factor: 5.435

5.  The Analysis of Oxidative Stress Markers May Increase the Accuracy of the Differential Diagnosis of Alzheimer's Disease with and without Depression.

Authors:  Anna Polak-Szabela; Inga Dziembowska; Marietta Bracha; Agnieszka Pedrycz-Wieczorska; Kornelia Kedziora-Kornatowska; Mariusz Kozakiewicz
Journal:  Clin Interv Aging       Date:  2021-06-16       Impact factor: 4.458

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.